{"cluster": 62, "subcluster": 3, "abstract_summ": "Data from several countries show that few repurposed drugs using existing antiviral drugs have not (so far) been satisfactory and more recently were proven to be even highly toxic.Other emerging non-conventional drug discovery techniques such as bioinformatics and cheminformatics, structure-based drug design, network-based methods for prediction of drug-target interactions, artificial intelligence (AI) and machine learning (ML) and phage technique could provide alternative routes to discovering potent Anti-SARS-CoV2 drugs.While drugs are being repurposed and discovered for COVID-19, novel drug delivery systems will be paramount for efficient delivery and avoidance of possible drug resistance.Based on these discoveries, identifying potential targets involved in the processes of virus pathogenesis is urgently needed, and discovering or developing promising drugs based on potential targets is the most pressing need.We assess the scope for targetting key host and viral targets in the mid\u2010term, by first screening these targets against drugs already licensed; an agenda for drug re\u2010purposing, which should allow rapid translation to clinical trials.", "title_summ": "AI: Artificial Intelligence Pinpoints Remdesivir in Combination with Ritonavir and Lopinavir as an Optimal Regimen Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Potential Therapeutic Targets and Promising Drugs for Combating SARS\u2010CoV\u20102A rational roadmap for SARS\u2010CoV\u20102/COVID\u201019 pharmacotherapeutic research and development.IUPHAR Review 29Physicochemical properties of SARS\u2010CoV\u20102 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality controlDrug Development and Medicinal Chemistry Efforts toward SARS\u2010Coronavirus and Covid\u201019 TherapeuticsUpdate on therapeutic approaches and emerging therapies for SARS-CoV-2 virusVaccine development and therapeutic design for 2019\u2010nCoV/SARS\u2010CoV\u20102:Challenges and chancesIDentif.", "title_abstract_phrases": "Data from several countries show that few repurposed drugs using existing antiviral drugs have not (so far) been satisfactory and more recently were proven to be even highly toxic.Other emerging non-conventional drug discovery techniques such as bioinformatics and cheminformatics, structure-based drug design, network-based methods for prediction of drug-target interactions, artificial intelligence (AI) and machine learning (ML) and phage technique could provide alternative routes to discovering potent Anti-SARS-CoV2 drugs.While drugs are being repurposed and discovered for COVID-19, novel drug delivery systems will be paramount for efficient delivery and avoidance of possible drug resistance.This longer\u2010term strategy would provide a deeper pool of drug choices for future\u2010proofing against acquired drug resistance.Based on these discoveries, identifying potential targets involved in the processes of virus pathogenesis is urgently needed, and discovering or developing promising drugs based on potential targets is the most pressing need."}